This video is a recording of Prostate Cancer Foundation Canada's Coast to Coast Support Group meeting held over Zoom. Dr. Sofie Tolmeijer and Dr. Edmond Kwan from the Vancouver Prostate Centre discuss how tumour DNA testing and germline (genes inherited from one’s parents) testing will play an increasingly important role in selecting patients for new precision therapies. --- For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's June 2024 Advanced Prostate Cancer Support Group meeting held over Zoom. Alan Birch is the Associate Director of Provider Solutions Oncology at Sentrex Health. He is also the Founder of Drug Access Canada. You can see more information on their website, DrugAccess.ca. It provides resources for patients and health care providers. Alan started as an Oncology Drug Access Navigator at North York General Hospital in Toronto where he worked in the cancer centre for 8 years. At Sentrex, Alan created the prostate cancer patient support program called Haven. Alan and his colleague Brenda Bruinooge are speaking here on The Haven Uro-Oncology Program. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's May 2024 Coast to Coast Support Group meeting held over Zoom. This is a joint presentation by Dr. Anthony Helou and Dr. Marc-André Morin. Anthony Helou is a leader in the pharmaceutical industry. He was involved in the introduction of important vaccines with Sanofi and Pfizer, including Pfizer-BioNTech's COVID-19 vaccine. He has a Doctor of Pharmacy degree from the University of Florida and is committed to advancing healthcare and pharmaceutical innovation. Dr. Marc-André Morin is a doctor specializing in Nuclear Medicine, practicing at the Center Hospitalier de l’Université de Montréal and at the Center Hospitalier Universitaire de Québec. He also holds a bachelor’s degree in Physiotherapy from McGill University and a Doctorate in Medicine from Laval University. At the same time, he is completing a master's degree in university teaching of health sciences at the University of Montreal. He is also known as the first doctor in Quebec to have infused radioligand treatment for prostate cancer. They are speaking here on Harnessing Radioligand Therappy: Innovative Solutions for Advanced Prostate Cancer. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's November 2023 Coast to Coast Support Group meeting held over Zoom. Dr. Shamini Selvarajah is a clinical laboratory geneticist and Assistant Professor in the Department of Laboratory Medicine & Pathobiology - Cytogenetics at the University of Toronto. She holds a PhD, FACMGG, and FCCMG. Dr. Selvarajah is speaking here on '2023 Update on Genetic Testing Recommendations for Prostate Cancer Patients.' For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's April 2024 Coast to Coast Support Group meeting held over Zoom. Danielle Ralic is the founder and CEO of Ancora.ai, a health tech company that connects cancer patients & their care teams to clinical trials through an AI-powered platform. She studied Finance and Information Systems with a specialty in Healthcare Information Technology at Boston College. She has over 15 years of experience implementing technology solutions in healthcare first with Deloitte in Boston working with hospitals and the public health department, and then at ZS Associates in Los Angeles and Zurich to deliver business intelligence solutions to Top10 Pharma. She is also an accomplished panelist and speaker sharing insights on advanced analytics applications in healthcare. Danielle is speaking here on Why We Should Care About Clinical Trials (And How to Stay in the Loop). For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's April 2024 Advanced Prostate Cancer Support Group meeting held over Zoom. Esteban Regalado is a nurse, and a former trauma RN specialist. Currently, he is the Director of Physician Education and Engagement for Telix Pharmaceuticals. He is a member of the Medical Science Liaison Society and the Society of Nuclear Medicine Molecular Imaging. Esteban Regalado is speaking here on on Advanced Prostate Cancer - Diagnostics and Treatments. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Foundation Canada's Coast to Coast support group meeting in August 2023 featuring Alex Rolland and Michelle Morand of Cancer Treatment Options and Management (CTOAM). The organization is a team of researchers and educators with diverse backgrounds in cell biology, biochemistry, immunology, oncology, and clinical cancer. They are committed to ensuring that patients are aware of, and have access to, the most effective treatment available for their cancer, maximizing the success of the treatment, and limiting side effects as much as possible. CTOAM will work and communicate with your urologist or oncologist to achieve the best results in your journey with cancer. For more information about Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) and the support it provides to prostate cancer patients and their loved ones across Canada, please visit prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Prostate Cancer Canada's March 2023 Coast to Coast Support Group meeting held over Zoom. Dr. John Bell is a Senior Scientist at the Ottawa Hospital Research Institute. Dr. Bell is speaking here on immunotherapy for prostate cancer. For more information on Prostate Cancer Foundation BC (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of Dr. Philip Cohen speaking at the January 2023 Coast to Coast Support Group meeting. Dr. Cohen speaks here about the role that 'theranostics' play in nuclear medicine in prostate cancer and emerging therapies. For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) please visit prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

The 2022 Prostate Cancer Virtual Conference presented by Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) took place over the weekend of September 17th and 18th. The second day of the Conference, 'Prostate Cancer Realities,' focussed on what prostate cancer patients need to know while on their prostate cancer journeys. Dr. Linda Carlson, Psychosocial Oncologist, speaks here on managing anxiety and difficult emotions along your cancer journey with mindfulness. For more information on Prostate Cancer Foundation Canada, please visit prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

The 2022 Prostate Cancer Virtual Conference presented by Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) took place over the weekend of September 17th and 18th. The second day of the Conference, 'Prostate Cancer Realities,' focussed on what prostate cancer patients need to know while on their prostate cancer journeys. This video shows Dr. Richard Wassersug, research scientist, speaking on safely researching prostate cancer on the internet and how to determine if websites are reputable. For more information on Prostate Cancer Foundation Canada, please visit prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of the December 2022 Coast to Coast prostate cancer support group meeting. - For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) please visit prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

The ‘advanced prostate cancer’ experience is quite different from stories told at ‘regular’ prostate cancer support meetings - in terms of treatment approach, side effects, intensity, and emotional impact. The Advanced Prostate Cancer Forum is a celebration of the unique journeys of men diagnosed with advanced prostate cancer and their partners/caregivers - their triumph over relatively daunting challenges. This forum also provides opportunity for ‘regular’ prostate cancer survivors to learn more about their ‘advanced’ colleagues. Five men diagnosed with advanced prostate cancer, and a partner will (in turn) share their prostate cancer experiences; followed by a Q&A session involving spontaneous exchanges with attendees. This forum promises to be an uplifting experience for all. Visit advancedprostatecancer.ca to get connected with fellow advanced patients.

This video is a recording of the July 2022 Vancouver prostate cancer support group meeting discussing bone metastasis in prostate cancer. Felipe Eltit is a dentist from Chile. He studied tooth structure and mechanical properties in his native country. He came to Canada aiming to specialize in biomaterials to understand the interaction between teeth and restorations. While working in Dr. Michael Cox's research lab, he understood that bone metastasis is the major cause of pain in patients with prostate cancer that can lead to bone fractures and spinal cord compression. He decided then to use his background in biomaterials and bone structure to study the effects of prostate cancer in the bone, aiming to relieve pain and increase the quality of life of prostate cancer patients. To learn more about the support that Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC) provides please visit prostatecanada.ca The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is a recording of a May 2022 Vancouver Prostate Cancer Support Group meeting. Edmond Kwan, MD, PhD is a UBC Postdoctoral Fellow in the Urologic Sciences Department, working at the Vancouver Prostate Centre. Edmond received his M.D. in 2009 and completed his Medical Oncology Training in Melbourne, Australia in 2017 with a strong interest in the care of patients with genitourinary cancers. He completed his Ph.D. at Monash University in July 2020 focusing on whole blood transcriptomics to identify biomarkers in advanced prostate cancer. His studies were supported by a scholarship from the National Health and Medical Research Council. During his Ph.D., he was actively involved in clinical research as a Principal Investigator and led various local and international clinical trials. In July 2021, supported by a UBC Killam Fellowship, he joined the Wyatt Lab at the Vancouver Prostate Centre to systemically study the genomic landscape of de novo metastatic prostate through the analysis of ctDNA and tumour tissue. --- The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

This video is an excerpt from a national Prostate Cancer Support Group meeting presented by Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC). Dr. Richard Wassersug is a research, Honorary Professor at UBC, author of author of 'Androgen Deprivation Therapy: An Essential Guide for Prostate Cancer Patients and Their Loved Ones,' and most proudly, a prostate cancer patient himself. This lecture speaks about maintaining quality of life despite the many side effects of hormone or Androgen Deprivation Therapy treatment for prostate cancer; it is focussed on both the patient, and partner, perspective. The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

In honour of Prostate Cancer Awareness Month, Dr. Abby Collier spoke at our Prostate Cancer Awareness Month 2021 Speaker Series. Prostate cancer (PCa) affects Canadian citizens widely and is one of the most common cancers diagnosed in either genders. As time has progressed we have become better at diagnosing and treating PCa. However scientific and medical efforts continue to push the boundaries of diagnosis and therapy. In this presentation Dr Collier will present some of the newly approved diagnostics and therapeutics for PCa, including providing a broad overview of how these fields are developing from a research and clinical trial perspective. About Dr. Collier: Originally from New Zealand, Dr. Collier holds both a BSc and PhD in pharmacology from the University of Auckland. After a postdoctoral fellowship with Professor Chris Pritsos at the University of Nevada, Dr. Collier was an assistant professor, then associate professor at the University of Hawaii Medical School. A member of the Faculty of Pharmaceutical Sciences at UBC since 2013, Dr. Collier is professor of Drug Metabolism and Pharmacokinetics, teaches pharmacology to undergraduate, graduate, pharmacy and medical students, maintains an active and well-funded research lab and directs the new undergraduate BPSc degree program. Dr. Collier's sub-specialty is drug metabolism and pharmacokinetics. She is the winner of the 2021 Center for Alternatives to Animal Testing (CAAT) Award (biennial, world-wide) in recognition of her scientific research leading the field in modeling and simulation “to reduce, refine and replace animal use”. She uses a combination of laboratory work and computer modeling to improve drug/chemical safety and efficacy. Along with her collaborators, she also performs research and publishes regularly in the fields of human and environmental toxicology and endocrinology, including prostate cancer. --- The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of the Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.

In honour of Prostate Cancer Awareness Month, Dr. Phil Cohen, MD, FRCP(C), ABNM, joined our Coast to Coast Prostate Cancer Support Group Meeting as part of our Prostate Cancer Awareness Speaker Series. --- About Dr. Cohen: Dr. Philip Cohen is the Division Head of Nuclear Medicine at Lions Gate Hospital in Vancouver, Canada. He is the past chairman of the Diagnostic Accreditation Subcommittee for Nuclear Medicine of the British Columbia (B.C.) Medical Association and the B.C. College of Physicians, Member-at-Large of the Canadian Association of Nuclear Medicine, and Clinical Professor at the University of B.C. Dr Cohan has numerous publications and is a member of the editorial board of the Iranian Journal of Nuclear Medicine. He is a Fellow of the Royal College of Physicians and Surgeons of Canada in Nuclear Medicine, and also of the American Board of Nuclear Medicine. Dr. Cohen is a pioneer in Nuclear Medicine in Canada and in the usage of 3-D imaging techniques to improve diagnosis of bone disease and injury in collaboration with the Medical Imaging Research Group at University of British Columbia. Dr Cohen has been involved in clinical research trials of new radiopharmaceuticals. To that effect, he was the first recipient of a research grant from the Lions Gate Hospital Foundation, one of several peer-reviewed awards that would follow. --- The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.